Fire Prevention & Safety Grant Application Period Opens November 12

The FY 2018 Fire Prevention and Safety grant application period will open at 8 a.m. ET Monday, 12 November 2018 and will close on Friday, 21 December 2018 at 5 p.m. ET. The Fire Prevention and Safety Grants are part of the Assistance to Firefighters Grants and support projects that enhance the safety of the public and firefighters from fire and related hazards.

FLIR Systems Receives Development Contract Totaling $1.2M From the Department of Defense

FLIR Systems Inc. announced it has been awarded the first option phase on a five-year, cost-plus fixed fee contract by the United States Department of Defense’s Defense Threat Reduction Agency. This option totals $1.2 million for continued development of the FLIR Agentase C2 chemical agent disclosure spray (ADS) for detection of nerve agents and a new formulation for fentanyl detection.

Evolv Technology Awarded SAFETY Act Designation for Evolv Edge™

Evolv Technology today announced Evolv Edge™, its people screening system that detects weapons and bombs, has achieved the U.S. Department of Homeland Security (DHS) SAFETY Act Designation. Following a rigorous application and due diligence process by DHS, the Evolv Edge is now a Qualified Anti-Terrorism Technology (QATT).

Researchers Discover Potential Antidote to Botulism

Researchers have identified a compound that strongly inhibits botulinum neurotoxin, the most toxic compound known. That inhibiting compound, nitrophenyl psoralen (NPP), could be used as a treatment to reduce paralysis induced by botulism. Botulinum neurotoxin is considered a potential bioweapon because there is no U.S. Food and Drug Administration approved antidote.

FDA Approval of Anti-Seizure Drug Provides a New Tool for Protecting Americans During a Chemical Attack

The U.S. Food and Drug Administration approval of the drug Seizalam® (midazolam injection) as an anti-seizure medication, protects Americans from a potentially deadly health effect of chemical weapons. Having this drug, developed by Meridian Medical Technologies, available in multi-use vials makes drug administration easier in emergencies involving a large number of people exposed to chemicals that cause prolonged seizures.

New Virtual Tool Gives Responders, Educators an “EDGE” on School Safety

First responders and educators now have a tool at their disposal to help ensure the safety of the nation’s schools, as well as the students and faculty within them. The Enhanced Dynamic Geo-Social Environment (EDGE), a virtual training platform, allows teachers, school staff, law enforcement officers, and others tasked with school security to create and practice response plans for a wide range of critical incidents.

CU Researchers Provide Resource for Patient Care in Chemical and Biological Attacks

The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians. The authors describe how to recognize, diagnose, treat, and report exposures to anthrax, botulism, brucella, plague, smallpox, organophosphates, nerve agents, cyanide, or carfentanil.

FDA Approves New Drug to Treat Influenza

The U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. Flu is a contagious respiratory illness caused by influenza viruses. When patients with the flu are treated within 48 hours of becoming sick, antiviral drugs can reduce symptoms and duration of the illness.

Public Safety Agencies Pilot Artificial Intelligence to Aid in First Response

The Department of Homeland Security Science and Technology Directorate’s Next Generation First Responder Apex program partnered with the NASA Jet Propulsion Laboratory to address capability gaps and develop the Assistant for Understanding Data through Reasoning, Extraction, and Synthesis (AUDREY). AUDREY is a state-of-the-art human-like reasoning system designed to assist first responders in synthesizing high-level data while at the scene of an emergency.

Protecting our Future: Emergency Preparedness and Children’s Mental Health

Among the many lessons learned during the 2017 Hurricane season, the Centers for Disease Control and Prevention recognized that addressing children’s mental and behavioral health needs is a major concern in hurricane-affected areas. CDC’s At Risk Task Force was established in 2017 to ensure identification and prioritization of the mental and physical health needs of at-risk populations, including children.